Oral composition and application thereof

The invention discloses an oral composition and application thereof, the composition comprises 0.1-10 wt% of lysozyme and 0.1-1 wt% of paeonol, and the lysozyme is lysozyme containing a fig plant source. The sterilization performance of a final product compounded by using the lysozyme and the paeono...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LU LIUHUA, OU ZHIHONG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention discloses an oral composition and application thereof, the composition comprises 0.1-10 wt% of lysozyme and 0.1-1 wt% of paeonol, and the lysozyme is lysozyme containing a fig plant source. The sterilization performance of a final product compounded by using the lysozyme and the paeonol is better than that of single use of one of the lysozyme and the paeonol, the limitation problem of single use is effectively solved, the effects of inhibiting bacteria, diminishing inflammation, easing pain and diminishing swelling are achieved, and the oral inflammation problem can be obviously and effectively solved. The lysozyme adopts fig plant source lysozyme, and compared with common animal lysozyme which only has the stability of about 1 month, the stability of the lysozyme is higher and can be prolonged to more than 3 years. 本发明公开了一种口腔组合物及其应用,该组合物包含0.1~10wt%溶菌酶和0.1~1wt%丹皮酚,所述溶菌酶为含无花果植物来源溶菌酶。本发明使用溶菌酶和丹皮酚复配复配后的最终产品的杀菌性能比单独使用其中一种都要表现优良,有效解决了单独使用的局限性问题,具有抑菌消炎、镇痛消肿的作用,能明显有效改善口腔炎症问题。溶菌酶采用无花果植物来源溶菌酶,相对常用的动物溶菌酶,